55 related articles for article (PubMed ID: 34636033)
1. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Breccia M; Abruzzese E; Accurso V; Attolico I; Barulli S; Bergamaschi M; Binotto G; Bocchia M; Bonifacio M; Caocci G; Capodanno I; Castagnetti F; Cavazzini F; Crisà E; Crugnola M; Stella De Candia M; Elena C; Fava C; Galimberti S; Gozzini A; Gugliotta G; Intermesoli T; Iurlo A; La Barba G; Latagliata R; Leonetti Crescenzi S; Levato L; Loglisci G; Lucchesi A; Luciano L; Lunghi F; Luzi D; Malato A; Cristina Miggiano M; Pizzuti M; Pregno P; Rapezzi D; Rege-Cambrin G; Rosti G; Russo S; Sancetta R; Rita Scortechini A; Sorà F; Sportoletti P; Stagno F; Tafuri A; Tiribelli M; Foà R; Saglio G
Br J Haematol; 2022 Feb; 196(3):559-565. PubMed ID: 34636033
[TBL] [Abstract][Full Text] [Related]
2. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
El-Ashwah S; Salmanton-García J; Bilgin YM; Itri F; Žák P; Weinbergerová B; Verga L; Omrani AS; Silva MGD; Szotkowski T; Marchetti M; Buquicchio C; Nucci M; Schönlein M; Farina F; Besson C; Prezioso L; Nizamuddin S; Dávila-Valls J; Martín-Pérez S; Bonuomo V; Van Doesum J; Tisi MC; Passamonti F; Méndez GA; Meers S; Maertens J; López-García A; Glenthøj A; Bonnani M; Rinaldi I; Ormazabal-Vélez I; Labrador J; Kulasekararaj A; Espigado I; Demirkan F; De Jonge N; Collins GP; Calbacho M; Blennow O; Al-Khabori M; Adžić-Vukičević T; Arellano E; Mišković B; Mladenović M; Nordlander A; Ráčil Z; Ammatuna E; Cordoba R; Hersby DS; Gräfe S; Emarah Z; Hanakova M; Sacchi MV; Ijaz M; Rahimli L; Nunes Rodrigues R; Zambrotta GPM; Marchesi F; Cornely OA; Pagano L
Leuk Lymphoma; 2024 Feb; 65(2):199-208. PubMed ID: 37966980
[TBL] [Abstract][Full Text] [Related]
3. SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation.
Sorà F; Chiusolo P; Laurenti L; Innocenti I; Autore F; Alma E; Viscovo M; Fusco D; Maresca M; Tumbarello M; Sica S
Transfus Apher Sci; 2020 Dec; 59(6):102881. PubMed ID: 32828694
[TBL] [Abstract][Full Text] [Related]
4. Covid-19, leukemia, and secondary malignancies of the skin - is there a connection: a case report and literature analysis.
Bogomolets O; Rojczyk E; Hryshchenko R; Bogomolets C; Berezkin O
Front Oncol; 2023; 13():1265479. PubMed ID: 37965467
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
6. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wilson WH; Wright GW; Huang DW; Hodkinson B; Balasubramanian S; Fan Y; Vermeulen J; Shreeve M; Staudt LM
Cancer Cell; 2021 Dec; 39(12):1643-1653.e3. PubMed ID: 34739844
[TBL] [Abstract][Full Text] [Related]
7. Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools.
Castagnetti F; Binotto G; Capodanno I; Billio A; Calistri E; Cavazzini F; Crugnola M; Gozzini A; Gugliotta G; Krampera M; Lucchesi A; Merli A; Miggiano MC; Minotto C; Poggiaspalla M; Salvucci M; Scappini B; Tiribelli M; Trabacchi E; Rosti G; Galimberti S; Bonifacio M
Target Oncol; 2021 Nov; 16(6):823-838. PubMed ID: 34661826
[TBL] [Abstract][Full Text] [Related]
8. Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.
Rodríguez-Mora S; Corona M; Solera Sainero M; Mateos E; Torres M; Sánchez-Menéndez C; Casado-Fernández G; García-Pérez J; Pérez-Olmeda M; Murciano-Antón MA; López-Jiménez J; Coiras M; García-Gutiérrez V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894433
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Patients with Chronic Myeloid Leukemia and COVID-19 Infection-A Single Center Survey.
Ćojbašić I; Golubović I; Ćojbašić Ž
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763683
[No Abstract] [Full Text] [Related]
10. Management of chronic myelogenous leukemia with COVID-19 and hepatitis B.
Yu T; Li W; Yu T
Front Oncol; 2023; 13():1217023. PubMed ID: 37601670
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era.
Qi F; Bao M; Gao H; Zhang X; Zhao S; Wang C; Li W; Jiang Q
Ann Hematol; 2023 Oct; 102(10):2707-2716. PubMed ID: 37578540
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia.
Cheng F; Xiang H; Gale RP; Chen S; Qu J; Guo H; Li Q; Zhang Y; Li W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11025-11030. PubMed ID: 37337067
[TBL] [Abstract][Full Text] [Related]
13. Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
Civettini I; Antolini L; Brioschi F; Zambrotta GPM; Guglielmana V; Gambacorti-Passerini C
Cancer Med; 2023 Apr; 12(8):9662-9667. PubMed ID: 37039261
[TBL] [Abstract][Full Text] [Related]
14. The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.
Dahlén T; Flygt H; Lübking A; Olsson-Strömberg U; Wennström L; Dreimane A; Själander A; Leach S; Gisslén M; Li H; Höglund M; Stenke L; Nyberg F
Leukemia; 2023 May; 37(5):1156-1159. PubMed ID: 37037908
[No Abstract] [Full Text] [Related]
15. COVID-19 in patients with chronic myeloid leukaemia on tyrosine kinase inhibitor therapy: a Honduran observational study.
Fajardoa CJ; Cálixb ES; Mojicac R; Duarted F
Ecancermedicalscience; 2022; 16():1481. PubMed ID: 36819815
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Milojkovic D; Reynolds CJ; Sandoval DM; Pieper FP; Liu S; Pade C; Gibbons JM; McKnight Á; Loaiza S; Palanicawander R; Innes AJ; Claudiani S; Apperley JF; Altmann DM; Boyton RJ
Leukemia; 2023 Jan; 37(1):244-247. PubMed ID: 36528708
[No Abstract] [Full Text] [Related]
17. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.
Sertić Z; Lucijanić M; Bašić-Kinda S; Serventi Seiwerth R; Periša V; Sertić D; Coha B; Pulanić D; Perić Z; Desnica L; Mikulić M; Vodanović M; Radman-Livaja I; Šegulja D; Rogić D; Valković T; Aurer I; Duraković N
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428459
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase.
Yılmaz U; Küçükyurt S; Tunç S; Eşkazan AE
Front Oncol; 2022; 12():994101. PubMed ID: 36276065
[TBL] [Abstract][Full Text] [Related]
19. Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19.
Rodríguez-Mora S; Corona M; Torres M; Casado-Fernández G; García-Pérez J; Ramos-Martín F; Vigón L; Manzanares M; Mateos E; Martín-Moro F; Zurdo-Castronuño A; Murciano-Antón MA; Alcamí J; Pérez-Olmeda M; López-Jiménez J; García-Gutiérrez V; Coiras M; On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628927
[TBL] [Abstract][Full Text] [Related]
20. Management of Newly Diagnosed Chronic Myeloid Leukemia During COVID-19 Hospitalization: A Teaching Case.
Bangolo AI; Cherian J; Jandir P; Nasir Q; Lo A
Cureus; 2022 Apr; 14(4):e24093. PubMed ID: 35573502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
